日韩成人三级片,人人操操人人人,黄色AV一区二区,亚洲专一区,亚洲精品视频免费区,www.狠品,不卡观看AV,午夜不卡1卡2卡3,亚洲精品国产成人探花

×

R&D Progress

Guided by the philosophy of "building a global brand through continuous innovation", we constantly optimize our product mix and enrich our research pipelines. We devote ourselves to the development of medicines for diabetes and other endocrine disorders diseases, in a bid to enhance our market competitiveness and lead the domestic industry.

Milestones

  • 1985

    Fresh Ginseng oral liquid

  • 1989

    Zhennaoning Capsules

  • 1993

    Dongbao Gantai

  • 1998

    Human Insulin Injection (Gansuli?R)

  • 1999

    Isophane Protamine Human Insulin Injection(Gansulin?N)

  • 2002

    Mixed Protamine Human Insulin Injection(30R)(Gansulin?30R)

  • 2008

    Mixed Protamine Human Insulin Injection(50R)(Gansulin 50R?)

  • 2014

    Mixed Protamine Human Insulin Injection(40R)

  • 2019

    Insulin Glargine Injection

  • 2021

    Sitagliptin Phosphate Tablets

  • 2021

    Sitagliptin Phosphate and Metformin Hydrochloride Tablets

  • 2021

    Insulin Aspart Injection

  • 2022

    Insulin Aspart 30 Injection

  • 2022

    Insulin Aspart 50 Injection

  • 2022

    Repaglinide Tablets

  • 2023

    Empagliflozin Tablets

  • 2023

    Liraglutide Injection

  • 2025

    Etoricoxib Tablets

  • 1985

  • 1989

  • 1993

  • 1998

  • 1999

  • 2002

  • 2008

  • 2014

  • 2019

  • 2021

  • 2021

  • 2021

  • 2022

  • 2022

  • 2022

  • 2023

  • 2023

  • 2025

Product Pipeline

Product Name Indications Preclinical IND Clinical NDA
Mixed protamine zinc recombinant human insulin lispro injection 25R Diabetes requiring insulin therapy
Insulin Degludec and Liraglutide Injection Type 2 diabetes in adults
Ultra-fast Insulin Lispro Injection(BC Lispro) Type 1 diabetes in adults
Semaglutide Injection Type 2 diabetes in adults
THDBH110/THDBH110 Capsules (Oral Small-Molecule GLP-1 Receptor Agonist) Type 2 diabetes in adults
THDBH120 Injection (Dual GLP-1/GIP Receptor Agonist) Type 2 diabetes in adults
THDBH120 Injection (Dual GLP-1/GIP Receptor Agonist) Obesity
THDBH150/THDBH151 Tablets (XO/URAT1 Dual Inhibitor) Gout/hyperuricemia
刚察县| 威海市| 江口县| 崇阳县| 进贤县| 和硕县| 大邑县| 筠连县| 尤溪县| 旅游| 和顺县| 五家渠市| 新余市| 曲靖市| 张掖市| 大竹县| 自贡市| 禹州市| 黔西| 济宁市| 龙海市| 鹰潭市| 荔波县| 重庆市| 浙江省| 南通市| 邵阳市| 四川省| 德钦县| 和林格尔县| 襄城县| 通海县| 申扎县| 寿阳县| 承德市| 旺苍县| 那坡县| 清新县| 贺兰县| 新田县| 承德县|